Trastuzumab Recruiting Phase 3 Trials for Estrogen Receptor Positive Breast Cancer / HER-2 Positive Breast Cancer Treatment

IndicationsStatusPurposePhase
RecruitingTreatment3
clinicaltrials.gov IdentifierTitleDrugs
NCT02947685Randomized, Open Label, Clinical Study of the Targeted Therapy, Palbociclib, to Treat Metastatic Breast Cancer